Medical management of patients with disability due to arthritis.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000628:therapy*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D005260:Female; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009985:Orthopedics; D010003:Osteoarthritis / Q000628:therapy*; D010653:Phenylbutazone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000962:Antimalarials; D006046:Gold; D010653:Phenylbutazone; D001241:Aspirin; D011241:Prednisone; D007213:Indomethacin